Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMPICILLIN\SULBACTAM Cause Disease recurrence? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Disease recurrence have been filed in association with AMPICILLIN\SULBACTAM. This represents 0.5% of all adverse event reports for AMPICILLIN\SULBACTAM.

9
Reports of Disease recurrence with AMPICILLIN\SULBACTAM
0.5%
of all AMPICILLIN\SULBACTAM reports
2
Deaths
1
Hospitalizations

How Dangerous Is Disease recurrence From AMPICILLIN\SULBACTAM?

Of the 9 reports, 2 (22.2%) resulted in death, 1 (11.1%) required hospitalization, and 1 (11.1%) were considered life-threatening.

Is Disease recurrence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMPICILLIN\SULBACTAM. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does AMPICILLIN\SULBACTAM Cause?

Drug ineffective (258) Off label use (124) Pyrexia (98) Rash (98) Diarrhoea (93) Condition aggravated (83) Drug hypersensitivity (70) Pneumonia (68) Acute kidney injury (66) Drug eruption (66)

What Other Drugs Cause Disease recurrence?

NIRMATRELVIR\RITONAVIR (20,040) PREDNISONE (1,979) CYCLOPHOSPHAMIDE (1,689) RITUXIMAB (1,588) METHOTREXATE (1,401) DOXORUBICIN (980) VINCRISTINE (932) PREDNISOLONE (873) MYCOPHENOLATE MOFETIL (852) DEXAMETHASONE (784)

Which AMPICILLIN\SULBACTAM Alternatives Have Lower Disease recurrence Risk?

AMPICILLIN\SULBACTAM vs AMPRENAVIR AMPICILLIN\SULBACTAM vs AMPYRA AMPICILLIN\SULBACTAM vs AMRUBICIN AMPICILLIN\SULBACTAM vs AMSACRINE AMPICILLIN\SULBACTAM vs ANAGRELIDE

Related Pages

AMPICILLIN\SULBACTAM Full Profile All Disease recurrence Reports All Drugs Causing Disease recurrence AMPICILLIN\SULBACTAM Demographics